News & Perspective

Dec 17, 2012

Dec 17, 2012

H5N1 researchers question proposed HHS funding framework

(CIDRAP News) – Federal health officials are in the midst of crafting a framework for funding H5N1 avian influenza gain-of-function studies, and today at a workshop they heard varied feedback from researchers, biosecurity experts, and others.

Dec 13, 2012

Dec 13, 2012

Global study notes progress against infectious diseases

(CIDRAP News) – Infectious diseases are causing fewer deaths and illnesses worldwide than two decades ago, with fewer kids dying, but younger and middle-aged adults are bearing more of the overall medical burden, according to a massive multipart study published today in The Lancet.

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Nov 19, 2012

Nov 19, 2012

E coli linked to fresh greens sickens 28 in five states

(CIDRAP News) – Federal and state health officials are investigating an Escherichia coli O157:H7 outbreak linked to mixed salad greens that has sickened at least 28 people in five East Coast states, most of them in New York.

Nov 15, 2012

Nov 15, 2012

Senate committee raises more meningitis outbreak questions

(CIDRAP News) – A Senate committee hearing today on the fungal meningitis outbreak covered some of the same ground as yesterday's House hearing but aired the views of compounding pharmacy industry groups and provided a strong example for strengthening the nation's public health infrastructure.

Nov 14, 2012

Nov 14, 2012

House committee grills FDA over fungal meningitis outbreak

(CIDRAP News) – The first congressional hearing today on the fungal meningitis outbreak linked to tainted steroids was marked by tough questions for regulators, political wrangling, and an appearance by the owner of the compounding pharmacy that produced the drugs, but he declined to testify.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»